All In Biotech

Free tool

FAERS Monitor: Bendeka

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208194 or its brand name (Bendeka, Bendamustine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

8,502

Serious

7,847

92% of reports

Hospitalization

3,305

Death reported

1,611

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,047
  • pyrexia581
  • disease progression512
  • covid-19412
  • drug ineffective405
  • product use in unapproved indication404
  • febrile neutropenia378
  • malignant neoplasm progression363
  • neutrophil count decreased360
  • neutropenia358
  • pneumonia350
  • platelet count decreased349
  • anaemia325
  • death295
  • myelosuppression276

Reports by year received

View as table
YearReports
20081
20093
20102
201115
2012129
201346
2014267
2015423
2016544
2017484
2018687
2019624
2020675
2021771
20221,484
20231,043
2024755
2025316
2026233

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,657 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neutrophil count decreasedSignal36022.019.97,159
myelosuppressionSignal27619.117.04,687
febrile neutropeniaSignal37814.212.84,603
disease progressionSignal51210.79.94,522
malignant neoplasm progressionSignal3638.88.02,504
platelet count decreasedSignal3498.17.32,177
neutropeniaSignal3586.55.91,677
covid-19Signal4125.85.31,650
anaemiaSignal3254.23.8802
pyrexiaSignal5814.23.81,412
product use in unapproved indicationSignal4044.03.7930
off label useSignal1,0473.02.81,414
pneumoniaSignal3502.72.4371
death2950.80.88
drug ineffective4050.80.732

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.